Related references
Note: Only part of the references are listed.Peptide vaccination directed against IDO1-expressing immune cells elicits CD8+and CD4+T-cell-mediated antitumor immunity and enhanced anti-PD1 responses
Souvik Dey et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs
Momir Bosiljcic et al.
BREAST CANCER RESEARCH (2019)
Delineating Pro-Angiogenic Myeloid Cells in Cancer Therapy
Benjamin W. Johnson et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Identification of a Novel Subset of Myeloid-Derived Suppressor Cells During Chronic Staphylococcal Infection That Resembles Immature Eosinophils
Oliver Goldmann et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
Lin Tian et al.
NATURE (2017)
Tumour ischaemia by interferon-γ resembles physiological blood vessel regression
Thomas Kammertoens et al.
NATURE (2017)
Myeloid-Derived Suppressor Cells
Dmitry I. Gabrilovich
CANCER IMMUNOLOGY RESEARCH (2017)
Issues with the Specificity of Immunological Reagents for Murine IDO1
Lee-Ann Van de Velde et al.
CELL METABOLISM (2016)
The end of the road for the tryptophan depletion concept in pregnancy and infection
Abdulla A. -B. Badawy et al.
CLINICAL SCIENCE (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment
Cara C. Schafer et al.
ONCOTARGET (2016)
IDO1 is an Integral Mediator of Inflammatory Neovascularization
Arpita Mondal et al.
EBIOMEDICINE (2016)
Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells
Thomas Condamine et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Interleukin-6 Stimulates Defective Angiogenesis
Ganga Gopinathan et al.
CANCER RESEARCH (2015)
Tumors: Wounds That Do Not Heal-Redux
Harold F. Dvorak
CANCER IMMUNOLOGY RESEARCH (2015)
Interleukin-6: An angiogenic target in solid tumours
Kathryn Middleton et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
The Stress-Response Sensor Chop Regulates the Function and Accumulation of Myeloid-Derived Suppressor Cells in Tumors
Paul T. Thevenot et al.
IMMUNITY (2014)
IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation
Richard Metz et al.
INTERNATIONAL IMMUNOLOGY (2014)
Specific In Situ Detection of Murine Indoleamine 2, 3-Dioxygenase
Sunil Thomas et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2014)
Myeloid-Derived Suppressor Cells Are Involved in Lysosomal Acid Lipase Deficiency Induced Endothelial Cell Dysfunctions
Ting Zhao et al.
JOURNAL OF IMMUNOLOGY (2014)
Noncanonical NF-κB Activation Mediates STAT3-Stimulated IDO Upregulation in Myeloid-Derived Suppressor Cells in Breast Cancer
Jinpu Yu et al.
JOURNAL OF IMMUNOLOGY (2014)
IFNγ-responsiveness of endothelial cells leads to efficient angiostasis in tumours involving down-regulation of DII4
Jingjing Deng et al.
JOURNAL OF PATHOLOGY (2014)
GCN2-Dependent Metabolic Stress Is Essential for Endotoxemic Cytokine Induction and Pathology
Haiyun Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR
Ulrike M. Litzenburger et al.
ONCOTARGET (2014)
Indoleamine 2,3 dioxygenase and metabolic control of immune responses
David H. Munn et al.
TRENDS IN IMMUNOLOGY (2013)
Pharmacological brake-release of mRNA translation enhances cognitive memory
Carmela Sidrauski et al.
ELIFE (2013)
A novel angiopoietin-derived peptide displays anti-angiogenic activity and inhibits tumour-induced and retinal neovascularization
G. M. Palmer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development
Courtney Smith et al.
CANCER DISCOVERY (2012)
Immature myeloid cells accumulate in mouse placenta and promote angiogenesis
Ofer Fainaru et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2011)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz et al.
NATURE (2011)
TGF-β Receptor II Loss Promotes Mammary Carcinoma Progression by Th17-Dependent Mechanisms
Sergey V. Novitskiy et al.
CANCER DISCOVERY (2011)
Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes
Madhav D. Sharma et al.
BLOOD (2009)
Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis
Kip M. Connor et al.
NATURE PROTOCOLS (2009)
Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression
Stephanie K. Bunt et al.
CANCER RESEARCH (2007)
Opinion - Angiogenesis: an organizing principle for drug discovery?
Judah Folkman
NATURE REVIEWS DRUG DISCOVERY (2007)
Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine
MB Nilsson et al.
CANCER RESEARCH (2005)
GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase
DH Munn et al.
IMMUNITY (2005)
Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease
P Sinha et al.
JOURNAL OF IMMUNOLOGY (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
Tryptophan and the immune response
JR Moffett et al.
IMMUNOLOGY AND CELL BIOLOGY (2003)
Share Paper
